Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

William Bragg

Anesthesiology Charleston, WV Medical Doctor

NPI 1437473287 CMS profile 1289769

3508 Staunton Ave Se, Charleston, WV 25304

Open in the dashboard

General payments

$311

10 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Bragg of Charleston, WV is reported in the CMS Open Payments database as having received $311 across 10 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $180 7
2023 General $20 1
2021 General $111 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Bragg
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to William Bragg were reported at $180. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year William Bragg Anesthesiology median Middle half National median
2019 $0 $72 $23–$151 $163
2020 $0 $36 $17–$120 $114
2021 $111 $49 $21–$135 $132
2022 $0 $52 $22–$144 $149
2023 $20 $53 $23–$143 $160
2024 $0 $55 $25–$150 $164
2025 $180 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $169 6 payments
  2. Acacia Pharma Inc $111 2 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $25 1 payment
  4. Phathom Pharmaceuticals, Inc. $6 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $311 10 payments
Products named General payments · program years 2021–2025
  1. ENTYVIO $169 6 payments
  2. Byfavo $111 2 payments
  3. XIFAXAN $25 1 payment
  4. BARHEMSYS $23 1 payment
  5. VOQUEZNA $6 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$12,580

Medicare's payments for the services billed

Medicare patients

213

Average age 71

Services billed

230

129 women, 84 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Ischemic heart disease 40%
Diabetes 39%
Depression 29%
Chronic kidney disease 24%
Atrial fibrillation 17%
COPD 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

10 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record